Abstract
Danggui Sini decoction (DSD), a famous Chinese medicine, has been used therapeutically in various diseases. In this study, we tried to investigate whether and how DSD could ameliorate myelosuppression in an animal model, in which myelosuppression is induced by cyclophosphamide treatment. The myelosuppression model was established by intraperitoneal injection of 100 mg/kg cyclophosphamide in mice. Flow cytometry was used to assess cell numbers and evaluate the bone marrow cell cycle distribution. Spleen samples were collected, and the mRNA expression levels of thrombopoietin (TPO) and c-Mpl were analyzed by RT-PCR. Our results demonstrated that DSD could significantly elevate the level of bone marrow hematopoietic stem progenitor cells in myelosuppression mice model. DSD also accelerated cell proliferation by switching cell cycles from G0/G1 phase to S and G2/M phase. Moreover, DSD significantly elevated the mRNA expression level of TPO, but not c-Mpl in spleen. Overall, the present results indicated that DSD is a promising Chinese medicine that is highly potent to ameliorate myelosuppression induced by chemotherapy by upregulating TPO expression.
Similar content being viewed by others
References
Zhao, A. B., Yu, B., Wu, X. L., et al. (2011). Protective effects on myelosuppression mice treated by three different classic Chinese medicine formulae. Pharmacognosy magazine, 7, 133–140.
Maxwell, M. B., & Maher, K. E. (1992). Chemotherapy-induced myelosuppression. Seminars in Oncology Nursing, 8, 113–123.
Lionne-Huyghe, P., Kuhnowski, F., Coiteux, V., et al. (2006). Indications of G-CSF administration in hematologic disorders. Bulletin du Cancer, 93, 453–462.
Wu, Y. J., Luo, S. F., Yang, S. H., et al. (2008). Vascular response of Raynaud’s phenomenon to nifedipine or herbal medication (duhuo-tisheng tang with danggui-sini tang): A preliminary study. Chang Gung Medical Journal, 31, 492–502.
You, W. H., Wang, P., Li, M. Q., et al. (2009). Therapeutic effects of modified Danggui Sini Decoction on plasma level of advanced glycation end products in patients with Wagner grade 0 diabetic foot: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao, 7, 622–628.
Zheng, J. P. (2005). Experience in clinical application of Danggui Sini Decoction. Zhong Xi Yi Jie He Xue Bao, 3(289), 293.
Yao, J. M., Yu, L. J., Chen, Q., et al. (2014). Comparison of ferulic acid content in Radix Angelicae Sinensis, Danggui-Buxue-Tang and Danggui-Sini-Tang. Experimental and Therapeutic Medicine, 7, 1364–1368.
Wagemaker, G., Neelis, K. J., Hartong, S. C. C., et al. (1998). The efficacy of recombinant TPO in murine And nonhuman primate models for myelosuppression and stem cell transplantation. Stem Cells, 16(Suppl 2), 127–141.
Abina, M. A., Tulliez, M., Lacout, C., et al. (1998). Major effects of TPO delivered by a single injection of a recombinant adenovirus on prevention of septicemia and anemia associated with myelosuppression in mice: risk of sustained expression inducing myelofibrosis due to immunosuppression. Gene Therapy, 5, 497–506.
Abushullaih, B. A., Pestina, T. I., Srivastava, D. K., et al. (2001). A schedule of recombinant Mpl ligand highly effective at preventing lethal myelosuppression in mice given carboplatin and radiation. Experimental Hematology, 29, 1425–1431.
Pestina, T. I., Cleveland, J. L., Yang, C., et al. (2001). Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis. Blood, 98, 2084–2090.
Farese, A. M., Smith, W. G., Giri, J. G., et al. (2001). Promegapoietin-1a, an engineered chimeric IL-3 and Mpl-L receptor agonist, stimulates hematopoietic recovery in conventional and abbreviated schedules following radiation-induced myelosuppression in nonhuman primates. Stem Cells, 19, 329–338.
Farese, A. M., MacVittie, T. J., Lind, L. B., et al. (1998). The combined administration of daniplestim and Mpl ligand augments the hematopoietic reconstitution observed with single cytokine administration in a nonhuman primate model of myelosuppression. Stem Cells, 16(Suppl 2), 143–154.
Sunohara, M., Morikawa, S., Fuse, A., et al. (2014). GATA-dependent regulation of TPO-induced c-mpl gene expression during megakaryopoiesis. Okajimas Folia Anatomica Japonica, 90, 101–106.
Wang, Q., Sun, R., Wu, L., et al. (2013). Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling. International Journal of Biochemistry & Cell Biology, 45, 2852–2863.
Kanai, S., Okano, H., & Abe, H. (1997). Efficacy of toki-shigyakuka-gosyuyu-syokyo-to (danggui-sini-jia-wuzhuyu-shengjiang-tang) on peripheral circulation in autonomic disorders. American Journal of Chinese Medicine, 25, 69–78.
Tan, W., Liu, B., Barsoum, A., et al. (2013). Requirement of TPO/c-mpl for IL-17A-induced granulopoiesis and megakaryopoiesis. Journal of Leukocyte Biology, 94, 1303–1308.
Sunohara, M., Morikawa, S., Fuse, A., et al. (2013). Role of promoter element in c-mpl gene expression induced by TPO. Okajimas Folia Anatomica Japonica, 89, 131–135.
Andrade, J., Cablewski, T., Condie, G., et al. (2010). Zinc is not required for activity of TPO agonists acting at the c-Mpl receptor transmembrane domain. ACS Chemical Biology, 5, 741–745.
Puigdecanet, E., Espinet, B., Villa, O., et al. (2006). Detection of abnormalities of PRV-1, TPO, and c-MPL genes detected by fluorescence in situ hybridization in essential thrombocythemia. Cancer Genetics and Cytogenetics, 167, 39–42.
Hemavathy, K. C., Suppiah, K., Hashmi, G., et al. (2005). TPO/Mpl studies in agnogenic myeloid metaplasia. Cell Commun Signal, 3, 4.
Tong, W., & Lodish, H. F. (2004). Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. Journal of Experimental Medicine, 200, 569–580.
Kakeda, M., Kyuno, J., Kato, T., et al. (2002). Role of the thrombopoietin (TPO)/Mpl system: c-Mpl-like molecule/TPO signaling enhances early hematopoiesis in Xenopus laevis. Development, Growth & Differentiation, 44, 63–75.
Author information
Authors and Affiliations
Corresponding author
Additional information
Qing-quan Chen and Xuesong Han contributed equally to this work.
Rights and permissions
About this article
Cite this article
Chen, Qq., Han, X., Wang, Wm. et al. Danggui Sini Decoction Ameliorates Myelosuppression in Animal Model by Upregulating Thrombopoietin Expression. Cell Biochem Biophys 71, 945–950 (2015). https://doi.org/10.1007/s12013-014-0291-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-014-0291-z